About Gilead Sciences, Inc.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with global headquarters in Foster City, California.

For nearly 30 years, Gilead has been a leading innovator in the field of HIV, driving advances in treatment, prevention and cure research. Today, it’s estimated that more than 12 million people living with HIV globally receive antiretroviral therapy provided by Gilead or one of the company’s generic manufacturing partners.

吉立亞醫藥

吉立亞醫藥是一家以研究為基礎的生物製藥公司，在尚未滿足的醫療需求領域中，不斷發現及開發創新藥物, 並使之商業化。公司致力為全球危疾病患者，改善並簡化治療護理。吉立亞在全球超過35個國家開展業務，全球總部位於加利福尼亞州福斯特城。

過去三十年來，吉立亞一直是愛滋病領域的創新先驅，積極推動並改善愛滋病治療，預防和治愈研究。今天，估計全球有超過1200萬愛滋病患者，接受了吉立亞或學名藥生產夥伴提供的抗逆轉錄病毒療法。